Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:TWST
NasdaqGS:TWSTBiotechs

Twist Bioscience (TWST) Q2 Loss Deepens To US$0.71 EPS And Tests Margin Improvement Story

Q2 2026 earnings snapshot Twist Bioscience (TWST) has just posted Q2 2026 results with revenue of US$110.7 million and a basic EPS loss of US$0.71, alongside trailing twelve month revenue of US$409.5 million and a trailing EPS loss of US$1.34, giving investors a clear read on both the latest quarter and the recent run rate. Over the past six reported quarters, revenue has moved from US$88.7 million in Q1 2025 to US$110.7 million in Q2 2026, while quarterly basic EPS has ranged from a loss of...
NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle (CCI) Offering Value After Short Term Rebound And Multi Year Slump

If you are wondering whether Crown Castle stock is priced attractively right now, the recent mix of short term gains and longer term weakness makes the valuation story especially interesting. The share price closed at US$89.10, with returns of 3.4% over 7 days and 5.1% over 30 days. Year to date the stock is up 0.5%, but down 12.3% over 1 year, 10.2% over 3 years and 38.1% over 5 years. Recent headlines have focused on Crown Castle's position within U.S. telecom infrastructure and how...
NYSE:RCUS
NYSE:RCUSBiotechs

Is It Too Late To Consider Arcus Biosciences (RCUS) After Its 221% One Year Surge?

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox Taps Sunil Rao To Turn India Growth Into Monetization

Roblox (NYSE:RBLX) has appointed Sunil Rao as Managing Director for India. Rao is tasked with leading local strategy and supporting growth in one of Roblox's fastest expanding international markets. This is Roblox's first direct senior leadership hire in India, focused on expanding the creator ecosystem and user base. Roblox runs a user generated content gaming and social platform where players and creators interact through virtual worlds. As global gaming, social interaction and digital...
OM:BILL
OM:BILLPackaging

3 European Stocks Estimated To Be Trading Below Fair Value By As Much As 42.1%

As European markets navigate a landscape marked by stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index remains relatively stable, with corporate earnings showing positive momentum. Amid these conditions, identifying undervalued stocks becomes crucial for investors seeking opportunities that may offer potential value in a market where economic sentiment has dipped to its lowest since 2020.
XTRA:FYB
XTRA:FYBBiotechs

European Growth Leaders With High Insider Ownership

As European markets navigate a complex landscape of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained largely stable with slight positive momentum in corporate earnings. In this environment, stocks with high insider ownership can be particularly attractive to investors seeking growth opportunities, as they often indicate strong alignment between company leadership and shareholders' interests.
HLSE:KAMUX
HLSE:KAMUXSpecialty Retail

3 Promising European Penny Stocks With At Least €40M Market Cap

The European market has shown resilience, with the pan-European STOXX Europe 600 Index ending the week slightly up amid ongoing geopolitical uncertainties and fluctuating oil prices. In this context, investors often seek opportunities in less conventional areas like penny stocks, which despite being an older term, continue to represent potential value in smaller or emerging companies. By identifying those with robust financials and growth potential, investors can uncover promising...
WSE:PXM
WSE:PXMConstruction

Uncovering 3 European Hidden Gems with Strong Potential

As the pan-European STOXX Europe 600 Index remains relatively flat amid geopolitical uncertainties and fluctuating oil prices, investors are keenly observing the region's economic indicators, such as Germany's rising inflation and Spain’s increasing unemployment rate. In this environment, identifying stocks with strong potential often involves looking for companies that demonstrate resilience through positive earnings momentum and strategic positioning in key sectors.
OM:SFAB
OM:SFABInsurance

Top European Dividend Stocks To Consider In May 2026

As the European markets navigate a complex landscape marked by stalled geopolitical negotiations and fluctuating oil prices, investors are keenly observing how these factors might influence economic sentiment and corporate earnings. Amid this backdrop, dividend stocks stand out as appealing options for those seeking steady income streams, especially when market volatility is a concern.
NasdaqGS:COLL
NasdaqGS:COLLPharmaceuticals

What Collegium Pharmaceutical (COLL)'s Margin Pressure Ahead of Q1 2026 Earnings Means For Shareholders

Collegium Pharmaceutical, a specialty pain-medicine maker, is approaching its first-quarter 2026 earnings release on May 7, with Wall Street expecting earnings per share of US$1.52 amid recent downward estimate revisions. Investors are increasingly focused on the company’s shrinking adjusted operating margin and relatively small revenue base, which together raise questions about the durability of future profits. We’ll now examine how concerns about Collegium’s weakening operating margin...
NYSE:PBI
NYSE:PBICommercial Services

A Look At Pitney Bowes (PBI) Valuation After Mixed Q1 2026 Earnings And Raised Revenue Guidance

Pitney Bowes (PBI) has drawn fresh attention after first quarter 2026 earnings showed revenue of US$477.41 million, lower than a year earlier, alongside higher net income and raised full year revenue guidance. See our latest analysis for Pitney Bowes. The earnings release appears to have been a key catalyst, with the stock’s 30-day share price return of 40.89% and year to date share price return of 50.44% building on a very large 3-year total shareholder return. However, the 7-day share price...
LSE:SHEL
LSE:SHELOil and Gas

Is Shell (LSE:SHEL) Pricing LNG Growth And Energy Transition Risks Correctly?

Wondering if Shell at £33.13 a share is offering value or just riding sentiment? This breakdown will help you see what the current price actually reflects. The stock has returned 0.7% over the last 7 days, is down 6.5% over 30 days, yet sits on year to date and 1 year returns of 20.0% and 41.6%. This gives you mixed signals about both momentum and risk. Recent news coverage has focused on Shell's positioning in global energy markets and its role in the ongoing transition toward lower carbon...